11111 Flintkote Avenue
About VerogenVerogen serves those who pursue the truth. It’s about advancing next-generation sequencing to help unlock the true potential of forensic genomics.
CEO: Kirk Malloy
CSO: Cydne Holt
8 articles with Verogen
The two companies will collaborate to market Verogen’s forensically validated NGS workflows alongside QIAGEN’s full range of forensic-grade chemistries and sample prep automation.
GEDmatch, a pioneer in consumer genealogy, announced that it has joined with forensic genomics firm Verogen, Inc. in a move that allows the company to ensure ongoing privacy protections and enhance the customer experience for users of its website.
CFSRE and Verogen Team Up to Accelerate the Implementation of Next Generation Sequencing for Law Enforcement and Practitioner Communities
The Center for Forensic Science Research & Education and Verogen have entered into a collaborative agreement to establish CFSRE as a leader in the field of forensic Next Generation Sequencing, also known as Massively Parallel DNA Sequencing.
DNA profiles generated on a MiSeq® system were critical evidence in landmark Dutch case.
Cellmark and Verogen Collaborate to Make the Next Generation of Forensic DNA Analysis Available to UK Police
Cellmark Forensic Services and Verogen have signed a collaboration agreement to establish Cellmark as a United Kingdom center of excellence for forensic Next Generation Sequencing, also known as Massively Parallel DNA Sequencing.
The FBI manages NDIS to enable comparison of eligible DNA profiles contributed by participating federal, state, and municipal forensic laboratories.
Verogen, Inc., the world’s first sequencing company solely dedicated to forensic science, announced today that it will begin taking orders and shipping products in the Americas (including the U.S., Canada, Mexico, Central and South America) beginning February 22, 2018 and in EMEA (Europe, Middle East, Africa) and China beginning March 9, 2018.